Physician profile
Eric G Becker
NPI 1720182447
$7,408.23
in general payments reported to CMS, 2019-2025
38 companies · $879 in 2025
The $879 reported for 2025 was more than what 82% of Adult Medicine providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $887 · 2021: $1,768 · 2022: $1,234 · 2023: $753 · 2024: $1,079 · 2025: $879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,710.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,566.51 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $985.11 | 2019-2025 | Farxiga, Airsupra, Lokelma |
| Abbvie INC. | $629.20 | 2020-2025 | Ubrelvy, Qulipta |
| Abbott Laboratories | $522.75 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2, Tacticath Ablation Catheter, Sensor Enabled |
| Lilly USA, LLC | $416.14 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $391.65 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $323.37 | 2020-2024 | Xarelto, Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $290.81 | 2019-2025 | Jardiance, Tradjenta |
| Novartis Pharmaceuticals Corporation | $187.29 | 2019-2024 | |
| Amgen INC. | $185.96 | 2019-2020 | |
| Pfizer INC. | $169.29 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $159.84 | 2019-2022 | |
| Glaxosmithkline, LLC. | $152.53 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Sanofi-Aventis U.S. LLC | $149.33 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $148.12 | 2021-2025 | Gvoke Hypopen |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.